Trondheim, Norway

Arne Reidar Strøm

This inventor holds 3 USPTO granted patents. Top assignee: Sinvent as. Active years: 2006-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arne Reidar Strøm. Retrieved from https://idiyas.com/inventor/arne-reidar-strøm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Arne Reidar Strøm: Innovator in Nystatin Biosynthesis

Introduction

Arne Reidar Strøm is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of biotechnology, particularly in the area of nystatin biosynthesis. With a total of 3 patents to his name, Strøm's work has implications for the development of novel macrolide structures.

Latest Patents

Strøm's latest patent focuses on genes encoding a nystatin polyketide synthase and their manipulation and utility. The invention provides a nucleic acid molecule that includes various nucleotide sequences, which can facilitate the biosynthesis of nystatin and its derivatives. This innovative approach has the potential to enhance the synthesis of polyketides, which are important in pharmaceutical applications.

Career Highlights

Arne Reidar Strøm is associated with Sinvent AS, where he continues to advance his research and development efforts. His work is characterized by a commitment to exploring the genetic underpinnings of nystatin production, which is crucial for its therapeutic applications.

Collaborations

Strøm has collaborated with notable colleagues, including Sergey Zotchev and Olga Nikolayivna Sekurova. These partnerships have enriched his research and contributed to the advancement of biotechnology.

Conclusion

Arne Reidar Strøm's innovative work in nystatin biosynthesis exemplifies the impact of genetic research on pharmaceutical development. His contributions continue to shape the future of biotechnology and its applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…